Cancer de l’ovaire : la rechute précoce.

Related Articles

Cancer de l'ovaire : la rechute précoce.

Bull Cancer. 2017 May;104 Suppl 1:S32-S38

Authors: Pautier P, Kalbacher E, de la Motte Rouge T, Bonnetain F, Lesoin A

Abstract
OVARIAN CANCER: EARLY RELAPSE: Early relapse (primary or secondary) is defined by relapse of disease less than 6 months before the last infusion of chemotherapy (with a platinum compound). There is no carcinological surgical indication. Disease should be treated with a non-platinum single agent (pegylated liposomal doxorubicin, weekly paclitaxel, gemcitabine or topotecan). Bevacizumab can be added if patients have not already received it (level of proof 1, grade A).

PMID: 28625313 [PubMed - in process]

from ! Medicine by Alexandros G. Sfakianakis via a.lsfakia on Inoreader http://ift.tt/2sRUeH8
via IFTTT